254 related articles for article (PubMed ID: 1308526)
1. Comparison of two multidrug regimens in multibacillary leprosy.
Jadhav VH; Patki AH; Mehta JM
Indian J Lepr; 1992; 64(4):501-4. PubMed ID: 1308526
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of multidrug therapy with rifampicin, clofazimine and D.D.S. in multibacillary leprosy cases.
Kundu SK; Hazra SK; Chaudhury S; Chatterjee B
Indian J Lepr; 1984; 56(1):78-85. PubMed ID: 6548246
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of short term results in two multidrug regimens in multibacillary leprosy.
Singh RP; Tiwari VD; Chattopadhyay SP
Indian J Lepr; 1993; 65(2):173-80. PubMed ID: 8345231
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of multidrug therapy in multibacillary leprosy: a long-term follow-up of 34 multibacillary leprosy patients treated with multidrug regimens till skin smear negativity.
Shaw IN; Christian M; Jesudasan K; Kurian N; Rao GS
Lepr Rev; 2003 Jun; 74(2):141-7. PubMed ID: 12862255
[TBL] [Abstract][Full Text] [Related]
5. Once monthly rifampicin (1200 mg) plus daily dapsone (100 mg) and clofazimine (100 mg) in the initial treatment of lepromatous leprosy.
Chandorkar AG; Burte NP; Gade RK; Bulakh PM
Indian J Lepr; 1984; 56(1):63-70. PubMed ID: 6384381
[TBL] [Abstract][Full Text] [Related]
6. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
[TBL] [Abstract][Full Text] [Related]
7. Follow up of BL/LL patients on a slightly modified WHO regimen of multidrug therapy.
Katoch K; Ramu G; Ramanathan U; Sengupta U; Sreevatsa
Indian J Lepr; 1987; 59(1):36-43. PubMed ID: 3611859
[TBL] [Abstract][Full Text] [Related]
8. Effect of three-year multidrug therapy in multibacillary leprosy patients.
Li W; Ye G; Yang Z; Tao M; Luo J; Wang C; Ji F
Proc Chin Acad Med Sci Peking Union Med Coll; 1990; 5(1):37-40. PubMed ID: 2371263
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of two multidrug regimen in hospitalised multibacillary cases.
Chattopadhyay SP; Gupta CM; Bhate RD; Bhate RP; Sreevatsa
Indian J Lepr; 1989 Apr; 61(2):196-205. PubMed ID: 2746028
[TBL] [Abstract][Full Text] [Related]
10. Combined regimens of one year duration in the treatment of multibacillary leprosy--I. Combined regimens with rifampicin administered during one year.
Pattyn SR; Bourland J; Grillone S; Groenen G; Ghys P
Lepr Rev; 1989 Jun; 60(2):109-17. PubMed ID: 2671559
[TBL] [Abstract][Full Text] [Related]
11. A comparative study of the efficacy of WHO and IAL multidrug therapy regimens for leprosy--an in-vivo and in-vitro study.
Revankar CR; Mahadevan PR; Ganapati R
Indian J Lepr; 1986; 58(4):543-8. PubMed ID: 3553361
[TBL] [Abstract][Full Text] [Related]
12. Prospective study on the relationship between intensive bactericidal therapy and leprosy reactions.
Groenen G; Janssens L; Kayembe T; Nollet E; Coussens L; Pattyn SR
Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):236-44. PubMed ID: 3722962
[TBL] [Abstract][Full Text] [Related]
13. Paucibacillary leprosy: a comparative study of different schedules of multidrug therapy.
Ramakrishnan KR; Arora PN; Aggarwal SK; Ramachandra S
Indian J Lepr; 1988 Oct; 60(4):542-8. PubMed ID: 3253333
[TBL] [Abstract][Full Text] [Related]
14. [Effect of rifampicin, clofazimine and dapsone in treating 296 cases of multibacillary leprosy].
Li WZ
Zhonghua Yi Xue Za Zhi; 1987 Jan; 67(1):1-3. PubMed ID: 3109697
[No Abstract] [Full Text] [Related]
15. Experience with multidrug therapy in paucibacillary leprosy.
Bhate RD; Gupta CM; Chattopadhyay SP; Singh IP
Indian J Lepr; 1986; 58(2):244-50. PubMed ID: 3805797
[TBL] [Abstract][Full Text] [Related]
16. Effect of clofazimine and dapsone on rifampicin (Lositril) pharmacokinetics in multibacillary and paucibacillary leprosy cases.
Mehta J; Gandhi IS; Sane SB; Wamburkar MN
Indian J Lepr; 1985; 57(2):297-310. PubMed ID: 4078356
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapeutic trials with different regimens containing rifampicin in paucibacillary type of leprosy cases--a preliminary report.
Katoch K; Ramu G; Ramanathan U
Indian J Lepr; 1985; 57(3):499-506. PubMed ID: 3831087
[TBL] [Abstract][Full Text] [Related]
18. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
Sapkota BR; Shrestha K; Pandey B; Walker SL
Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy trial with a triple-drug regimen, including once-monthly Rimactane (Rifampicin), in patients with multibacillary types of leprosy.
Reyes-Javier PD; Tantiongco PR
Acta Leprol; 1983; 1(3):133-41. PubMed ID: 6359801
[No Abstract] [Full Text] [Related]
20. Three years assessment of multidrug therapy in multibacillary leprosy cases.
Ganapati R; Revankar CR; Pai RR
Indian J Lepr; 1987; 59(1):44-9. PubMed ID: 3611860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
